Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Ensurge Micropower ASA appoints Shauna McIntyre as new CEO to lead commercial scale-up
-
Form 8.3 - Unite Group plc
-
Formation Metals Mobilizes to Site in Preparation for Near-Term Fully Funded 10,000 Metre Drill Program at the Advanced N2 Gold Project; Closes Final Tranche, Increasing Exploration Budget to ~$5.7M
-
Ant International’s WorldFirst Accelerates SEA Growth with Malaysia MSB Licence
-
Performance Brokerage Services Advises on Sale of Dick Masheter Ford in Columbus, Ohio to Drive Choice
-
Outfit7: Ready to Explore? Talking Tom & Friends: World is Here!
-
Objectway Accelerates Its Growth Path Through an Investment From Cinven in Partnership With Its Founder Luigi Marciano and the Existing Management Team
-
oneZero appoints Adam Collins as Head of Institutional Sales, Americas and EMEA
-
Geotab at 25: Driving the Future of Connected Vehicles
-
IBA Notice of Half Year 2025 Results and Conference Call
-
SNIPR BIOME Raises EUR 35 Million Series B Financing to Advance CRISPR-Medicines Targeting Antimicrobial Resistance
-
Fingerprint Cards AB (publ): invitation to the second quarter 2025 results presentation
-
August 8: The Final of Singer 2025 - Seven Contestants Compete for the "King of Singers" Title
-
The VinFast VF 8 - A Well-Earned Achievement as Baby Boomers and Gen X Embrace a Tech-Forward Drive
-
Europe’s First Passive CLO ETF Launched by Palmer Square Capital Management
-
Transactions in connection with share buy-back program
-
US NCI Sponsors Senhwa Biosciences' Second Program-IND Submitted for Clinical Trial Targeting MYC-Aberrant Lymphoma
-
THC Gummies Launch in 2025: Delta-9, Sleep, and CBD Hybrid Editions
-
Suominen Corporation’s Half-Year Financial Report for January 1 – June 30, 2025: Performance impacted by trade environment, cost saving program progressing
-
Initiates second phase of share buy-back program
-
PetroTal Announces Q2 2025 Financial and Operating Results
-
Interim Report Q2 2025
-
Harvia’s Half-year financial review 1 January – 30 June 2025
-
accesso® and Six Flags Extend 20-Year Ticketing Partnership with New 5-Year eCommerce Agreement
-
ViruSure launches pioneering first-in-class viral contamination test for biopharmaceuticals using Oxford Nanopore technology
-
Parade Technologies Reports Second Quarter 2025 Financial Results
-
Art Collective teamLab to Open New Museum, teamLab Biovortex Kyoto on October 7, 2025
-
Getlink SE: Shuttle Traffic in July 2025
-
Creative Safety Supply Highlights 5S Methodology Solutions for Enhanced Workplace Efficiency
-
Notice of Results and Investor Presentation
-
Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target
-
New AB Akola Group Investor Calendar for 2025/2026
-
NBPE - Transaction in Own Shares
-
Valeura Energy Inc. Announces Second Quarter 2025 Results
-
Notice of Results and Investor Presentation
-
Helium One Global Ltd Announces Result of Oversubscribed WRAP Retail Offer
-
TCM Group A/S: Major shareholder announcement
-
Shoucheng Highlights VC Role and Robot Lineup at WRC 2025
-
From Blockchain to Space: HTX Leads GM Vietnam 2025, Justin Sun's New Web3 Journey Takes Flight
-
FWD Group completes build-out of high-net-worth hub in Asia
-
US Investment Bank H.C. Wainwright Reiterates Buy Rating on IHC Portfolio Company, Phoenix Group, with AED 3.00 Target
-
AI Accounting Just Got Smarter: Better Business Advice Breaks Down QuickBooks' Task-Focused Agents
-
Allianz Announces Excellent Performance and Is Fully on Track for Full-year Ambitions
-
Transaction in Own Shares
-
Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information
-
ForFarmers results for the first half of 2025 (with full press release)
-
Onroutz.com and BookingWorldwide.net Set to Deliver World-Class Travel and Transportation for Toronto International Film Festival 2025
-
1st Semester 2025: Growth in Revenue to CHF 632.1m, up 12.3% at Constant Exchange Rates
-
1st Semester 2025: Growth in Revenue to CHF 632.1m, up 12.3% at Constant Exchange Rates
-
1st Semester 2025: Growth in Revenue to CHF 632.1m, up 12.3% at Constant Exchange Rates
